Enovis reports Q2 adjusted EPS 79c, consensus 72c

Reports Q2 revenue $565M, consensus $554.62M. Damien McDonald, Chief Executive Officer of Enovis (ENOV), said, “My first 90 days have strengthened my belief that Enovis has the foundation, portfolio, and momentum to drive durable, profitable growth. Realizing this potential will require continued operational discipline and a sharp focus on scalable, capital efficient execution. We are in the early stages of unlocking the full value of our orthopedic platform, and I’m excited to lead the Company with a commitment to continue helping millions of people lead full, active lives with a focus on creating shareholder value. Our second-quarter performance reflects the strength of our diversified global portfolio and the opportunity ahead. I’m grateful to the Board and the entire Enovis team for their support and alignment on our strategy.”